CD4 and neoplasm: Studies have shown that tumor-infiltrating immune cells such as B cells, CD4+ T cells, CD8+ T cells, neutrophils, macrophages, and dendritic cells can affect the efficacy of immunotherapy and the prognosis of cancer patients34, 35.